法国年龄与性别对经导管主动脉瓣置换使用的影响
该研究基于法国全国行政数据库,分析2015至2020年107,397例孤立主动脉瓣置换患者的年龄和性别相关趋势。结果显示,<65岁患者中TAVR比例增加63.2%但2020年仅占11.1%,≥65岁患者中TAVR占主导;女性更常接受TAVR且住院死亡率更高。
要点
- <65岁患者中TAVR使用增长但占比仍低,2020年为11.1%。
- ≥65岁患者中TAVR是主要方式,合并症和死亡率下降。
- 女性更常接受TAVR,但住院死亡率高于男性。
核心结论
- 在法国,年轻患者中TAVR使用仍不常见,主要限于高风险者。
- 性别在患者人口学、AVR方式选择和结局方面存在重要差异。
研究设计与样本
- 基于法国全国行政数据库的回顾性队列研究,纳入2015至2020年107,397例孤立主动脉瓣置换患者,44.0%为女性。
主要发现
- <65岁患者中TAVR比例从2015至2020年增加63.2%(P<0.001),但2020年仅占所有AVR的11.1%(女性12.4%,男性10.6%)。
- ≥65岁患者中TAVR是主导方式,其Charlson合并症指数和住院死亡率随年份下降(所有趋势P<0.001)。
- <65岁患者中TAVR者的Charlson合并症指数(趋势P=0.119)和住院死亡率(趋势P=0.740)无显著变化。
- 女性年龄更大(P<0.001)、Charlson合并症指数更低(P<0.001)、更可能接受TAVR(P<0.001),且住院死亡率更高(TAVR P=0.015;SAVR P<0.001),调整年龄和CCI后仍持续。
临床怎么用
- 年轻患者TAVR应用需谨慎评估,目前主要限于高风险者。
- 应关注AVR方式选择和结局的性别差异。
局限性
- 需进一步研究评估年轻患者TAVR的长期影响。
- 需前瞻性数据评估AVR方式选择和结局的性别差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Current guidelines recommend selecting surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR) based on age, comorbidities, and surgical risk. Nevertheless, reports from the United States suggest a rapid expansion of TAVR in young patients. OBJECTIVES: The authors sought to evaluate the trends in TAVR uptake at a nationwide level in France according to age and sex. METHODS: Using a nationwide administrative database, we evaluated age- and sex-related trends in TAVR uptake, patient demographics, and in-hospital outcomes between 2015 and 2020. RESULTS: A total of 107,397 patients (44.0% female) underwent an isolated aortic valve replacement (AVR) (59.1% TAVR, 40.9% SAVR). In patients <65 years of age, the proportion of TAVR increased by 63.2% (P < 0.001) from 2015 to 2020 but remained uncommon at 11.1% of all AVR by 2020 (12.4% in females, 10.6% in males) while TAVR was the dominant modality in patients ≥65 years of age. In patients undergoing TAVR, the Charlson comorbidity index (CCI) (P = 0.119 for trend) and in-hospital mortality (P = 0.740 for trend) remained unchanged in patients <65 years of age but declined in those ≥65 years of age irrespective of sex (all P < 0.001 for trends). Females were older (P < 0.001), had lower CCI (P < 0.001), were more likely to undergo TAVR (P < 0.001), and experienced higher in-hospital mortality (TAVR, P = 0.015; SAVR, P < 0.001) that persisted despite adjustment for age and CCI. CONCLUSIONS: In France, the use of TAVR remained uncommon in young patients, predominantly restricted to those at high risk. Important sex differences were observed in patent demographics, selection of AVR modality, and patient outcomes. Additional research evaluating the long-term impact of TAVR use in young patients and prospective data evaluating sex differences in AVR modality selection and outcomes are needed.
引用
- Prosperi-Porta G, Nguyen V, Willner N, et al. Association of Age and Sex With Use of Transcatheter Aortic Valve Replacement in France. J Am Coll Cardiol. 2023. PMID: 37877906. doi:10.1016/j.jacc.2023.08.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。